title: Validation and compliance of a home monitoring device in pregnancy: microlife WatchBP home.
abstract: OBJECTIVE
  To assess the accuracy and patient compliance in using a novel home blood pressure monitoring device in high-risk pregnancy.
  
  
  METHODS
  Device accuracy was assessed according to the British Hypertension Society protocol in 45 pregnant women, including 15 with preeclampsia. Twenty-one high-risk pregnant women used the device in addition to their antenatal care.
  
  
  RESULTS
  The device achieved a mean difference +/- SD of 0.4 +/- 7.3/-0.4 +/- 5.5 mmHg (pregnancy) and -2.6 +/- 7.0/0.8 +/- 4.4 mmHg (preeclampsia) for systolic/diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least 2 measurements/week.
  
  
  CONCLUSIONS
  The Microlife WatchBP Home is accurate for use in pregnancy and increases surveillance in compliant patients.
authors.affiliation: Maternal & Fetal Research Unit, King's College London, London, UK.
authors.forename: Yealin
authors.initials: Y
authors.lastname: Chung
authors.forename: Annemarie
authors.initials: A
authors.lastname: de Greeff
authors.forename: Andrew
authors.initials: A
authors.lastname: Shennan
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000502:physiology*; D018660:Blood Pressure Monitoring, Ambulatory / Q000379:methods*; D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000503:physiopathology; D011247:Pregnancy